Since the advent of controlled hypotension during anaesthesia and surgery in the 1950s, doubts have been expressed as to the adequacy of the cerebral circulation during the hypotensive period. Critical values of cerebral perfusion pressure (CPP), their correlations with the EEG and evoked potentials, and the pattern of brain damage produced by inadequate CPP were defined in the Rhesus monkey by Brierley and colleagues (1969) and Meldrum and Brierley (1969) . There is evidence that cerebral perfusion and oxygen metabolism are better maintained with sodium nitroprusside (SNP) than with trimetaphan (TMP) in the dog (Stoyka and Schutz, 1975; Michenfelder and Theye, 1977) and the cat (Maekawa, McDowall and Okuda, 1979) . In 1981, Ishikawa and McDowall confirmed that cerebral blood flow in the cat was greater at low arterial pressures with SNP than with TMP. In addition, they demonstrated a close relationship between the EEG (both assessed visually and processed by the Cerebral Function Monitor (CFM)) and the cortical cerebral blood flow. If these animal models are relevant to man, SNP would seem to be the agent of choice for induced hypotension.
Since the advent of controlled hypotension during anaesthesia and surgery in the 1950s, doubts have been expressed as to the adequacy of the cerebral circulation during the hypotensive period. Critical values of cerebral perfusion pressure (CPP), their correlations with the EEG and evoked potentials, and the pattern of brain damage produced by inadequate CPP were defined in the Rhesus monkey by Brierley and colleagues (1969) and Meldrum and Brierley (1969) . There is evidence that cerebral perfusion and oxygen metabolism are better maintained with sodium nitroprusside (SNP) than with trimetaphan (TMP) in the dog (Stoyka and Schutz, 1975; Michenfelder and Theye, 1977) and the cat (Maekawa, McDowall and Okuda, 1979) . In 1981, Ishikawa and McDowall confirmed that cerebral blood flow in the cat was greater at low arterial pressures with SNP than with TMP. In addition, they demonstrated a close relationship between the EEG (both assessed visually and processed by the Cerebral Function Monitor (CFM)) and the cortical cerebral blood flow. If these animal models are relevant to man, SNP would seem to be the agent of choice for induced hypotension.
To obtain an objective comparison of SNP and TMP during induced hypotension in man, we designed a controlled, single-blind study, with monitoring of the EEG (primarily by the CFM) to give presumptive evidence of the adequacy of cerebral perfusion. Since no anaesthetic technique used deviated from the standard practice of this hospital, no ethical approval was considered necessary. Correspondence to P. V. C. 
SUMMARY

During the routine use of controlled hypotension the electroencephalogram (EEG) and mean arterial pressure (MAP) were monitored in 20 normotensive patients (younger than 70 years-ofage) receiving either trimetaphan (TMP) or sodium nitroprusside (SNP
PATIENTS AND METHODS
Twenty patients undergoing major orthopaedic, gynaecological and plastic surgical procedures for which induced hypotension was routine practice, were allocated randomly to two groups (table I) . One group (mean age 53 ± 10.2 yr) received SNP, and the other (mean age 47 ± 15.3 yr) received TMP.
Patients were excluded if they were over 70 years-ofage; their diastolic arterial pressure exceeded All the patients were screened by one investigator before operation and premedicated with papaveretum 0.2 mg kg"' and hyoscine 4 \xg kg" 1 . After induction of anaesthesia and tracheal intubation, artificial ventilation (60% nitrous oxide and 0.5% halothane in oxygen) was instituted, neuromuscular blockade being provided by tubocurarine 0.5 mg kg" 1 . Before surgery, all patients received fentanyl 2-4 jig kg"
1 . TMP was prepared as a 0.2% solution in 5% dextrose and infused at a rate not exceeding 10 mg kg"' h " ' with an automatic infusion controller. SNP 0.01% in 5% dextrose was infused at a rate so as not to exceed a total dose of 1.5 mg kg" 1 (Cole, 1978) . Propranolol in 1-mg increments was administered if the mean arterial pressure (MAP) failed to reach the target value of 40 mm Hg with the maximum dose rate of hypotensive agent, or if the patient developed a tachycardia, defined as a heart rate greater than 80 beat min"
1 . MAP and end-tidal carbon dioxide concentration were displayed continually and recorded, on a chart recorder and a Racal "Store 4" tape recorder. Sterile intradermal EEG needle electrodes were placed in the left and right parietal regions, overlying the arterial boundary zones, with a third "guard" electrode in the mid-frontal region. The electrode sites were standardized by the use of a plastic template. The EEG signal was processed and displayed by a CFM on a polygraphic chart and both raw and processed signals stored on the tape recorder. Intermittent blood samples were taken to confirm normal alveolar ventilation, and to ensure adequate oxygenation and absence of metabolic acidosis.
The chart and tape recordings were marked with a numerical code for timing of events such as drug administration. They were analysed blind by two investigators not involved in the acquisition of the data.
Measurements were made manually of MAP and simultaneous average and minimum CFM voltage from the start of the administration of the hypotensive agent until arterial pressure had returned to a steady value once the drug had been discontinued.
The measurements were made at 10-s intervals during the initial decrease in arterial pressure towards the target value, and then at 50-s intervals during the remaining period of hypotension and the final increase in pressure. All CFM measurements were made in mm above the zero uV baseline. This represents the logarithmic transformation of the voltage information and gives a Gaussian distribution of data for statistical processing. They were subsequently converted to equivalent uV values. Each measurement was normalized by expression as a percentage of the mean of the three consecutive 50-s interval values immediately preceding the induction of hypotension. Measurements of minimum CFM value proved to have no advantage over average values and are not referred to further.
A replay of tape recordings of raw EEG signals permitted subsequent visual and automated assessment of alterations in frequency and voltage. Assessment of frequency information was based on visual inspection of the raw EEG traces and of analogue displays of the outputs of high-order Chebyshev filters (Etherington, 1981) , the modified CFM, the CFAM (Maynard and Jenkinson, 1984) and fast Fourier transform data (Matousek, Arvidsson and Friberg, 1978; Matousek and Petersen, 1983; Matousek etal., 1985) .
RESULTS
Mean arterial pressure decreased more slowly and reached the target value less often with TMP, whereas with SNP the decrease was rapid and sometimes overshot the target. The durations of hypotension and the mean decreases and the rates of decrease in MAP for patients receiving SNP and TMP, are presented in tables I and II. Expressed as percentages, the mean decreases in MAP were 37% and 51% for TMP and SNP, respectively.
Throughout the hypotensive period all patients appeared adequately perfused, with warm, pink extremities. Because of tachycardia or difficulty in achieving the target value of hypotension, 11 patients required P-blockade with propranolol: six of those receiving TMP and five of those receiving SNP.
In all 20 patients the average CFM voltage decreased during the initial reduction in arterial pressure. The decreases in mean voltage and the rates of decrease of the average CFM voltage for the two agents are given in table II. These represent mean decreases of 26% and 25% for patients receiving TMP and SNP, respectively. Thus, the decrease in CFM voltage was similar for the two agents in spite of a much greater decrease in MAP with SNP. No neurological or other sequelae were observed in any patient during the period immediately after operation.
There was a highly significant correlation between MAP and average CFM voltage during the initial reduction in arterial pressure in 10 out of the 20 patients regardless of agent, previous arterial pressure or age (tables I and II). When rates of decrease in arterial pressure were lower, there was a tendency to lower correlation coefficients between MAP and average CFM values. When the data, measured at 10-s intervals during the initial reduction in arterial pressure, are grouped according to agent, a significant difference in the relationship between average CFM value and MAP occurs at pressures in the range 55-40 mm Hg ( fig.  1 ). At MAP values less than 40 mm Hg, there were no data for patients receiving TMP. However, with SNP a progressive decrease in CFM voltage occurred.
In every patient an approximate MAP threshold could be identified from plots of all MAP and CFM voltage data throughout the period of hypotension, below which a pressure-dependent decrease in CFM voltage occurred ( fig. 2, table I ). The mean value was 57.4 ± 9.3 mm Hg. There was no relationship to age or to arterial pressure before operation. When the mean values for patients receiving TMP (54 ± 7 . 5 mm Hg) and for those receiving SNP (61 ± 9.94 mm Hg) were compared, a trend emerged, but did not reach statistical significance. As the amplitude of the CFM trace decreased (by a mean of 26%), the raw EEG, the Chebyshev filter outputs and the Fourier frequency analyses showed fairly consistent decreases in amplitude in all frequency bands. Comparing activity immediately before hypotension with that when the initial decrease in arterial pressure was complete, significant changes {P < 0.05 on Student's t tests) were seen in several variables in all patients. The significant alterations from the Fourier analysis all concerned amplitudes (square roots of power). Expressed as mean percentages in order of severity, these were: amplitude in the upper alpha (10-12.5 Hz) band, 25% decrease; amplitude in delta (1.5-3.5 Hz) band, 23% decrease; amplitudes in lower alpha (8-9.5 Hz) and lower beta (13-17 Hz) bands, both 18% decrease; sum of all amplitudes (1.5-25 Hz), 17% decrease. In all patients there were significant decreases in the sum of all the Fourier amplitudes in the 1.5-25 Hz range and the five CFAM amplitude measures (maximum, 90th centile, mean, 10th centile and minimum amplitudes). The significant changes in the other Fourier variables listed above occurred in the majority of patients, but were not universal. There were no significant alterations in frequency distribution, expressed as percentage of power in each band, in any patient. Frequency ratios, that is, of slow:fast EEG activity [(theta+delta)/(alpha+beta)] showed significant alterations (either an increase or a decrease) in only a minority of patients.
Significant correlations were shown between MAP and EEG measurements taken at 10-s intervals during the acute decrease in arterial pressure. The CFM showed the highest correlation with MAP (table II) , but also significant (P < 0.05) were the correlations between MAP and delta, upper alpha and lower beta amplitudes (correlation coefficients each 0.36) and lower alpha and theta amplitudes (correlation coefficients 0.22 and 0.18, respectively). Bearing in mind the loss of information as a result of occurrence of slow-wave artefact in recordings from the operating theatre, the amplitudes in the range 10-17 Hz appear to give the most reliable correlations with decreasing arterial pressure. 
DISCUSSION
We have shown that, in man, a decrease in MAP within the usual clinical range of controlled hypotension is reflected consistently in a decrease in cortical electrical activity (EEG). Furthermore, at mean arterial pressures between 55 and 40 mm Hg, the degree of depression is significantly greater with TMP than with SNP. These findings are in keeping with experimental evidence, particularly that of Ishikawa and McDowall (1981) . These authors showed that, at low MAP, cerebral blood flow was better maintained with SNP than with TMP. They also demonstrated the close correlation between the EEG ("power" being measured by the CFM) and cerebral blood flow during induced hypotension in the cat. This validated the use of EEG as a non-invasive indicator of the adequacy of blood flow or oxygenation in these circumstances. The EEG changes began at a mean arterial pressure threshold of 57 mm Hg, close to that at which autoregulation of cerebral blood flow normally fails (Lassen, 1959; Oleson, 1973) . The high correlation between decrease in average CFM voltage and MAP, which occurred in half the patients, does not appear to be predictable in terms of expected risk factors. The efficiency of the mechanisms governing autoregulation depends on the method used to induce hypotension and on its rate of administration (Fitch et al., 1976) , on the previous arterial pressure (Strandgaard et al., 1973; Strandgaard, 1976; Fitch etal., 1978) , the age of the subject (Hoffman, Albrecht and Miletich, 1982) and the rate of decrease in arterial pressure (Patel, 1981) . In our relatively small series of patients, we were unable to show any effects of either age or preoperative MAP. Both younger and older individuals appeared equally likely to show a strong correlation between decreasing arterial pressure and declining cortical electrical activity, whether the rate of decrease was in the higher range produced by SNP or the lower range produced by TMP. It should be borne in mind that we had excluded patients who were older than 70 yr or had previous hypertension or evidence or cerebrovascular disease. However, the implication must be that all patients, regardless of age, previous arterial pressure etc., are at risk from increasing cerebral oligaemia when their MAP is reduced below the value at which a decrease in EEG voltage begins.
Cerebral oligaemia, whatever its cause, leads to brain damage of a characteristic arterial boundary zone distribution (Graham, 1977; Brierley et al., 1980) . This pattern of cerebral infarction occurs in the Rhesus monkey when oligaemia during profound hypotension has resulted in at least 15 min EEG silence . Shorter periods of electrical silence were shown to be completely reversible without cerebral damage when adequate circulation was restored. This is the basis of the socalled dual threshold for cerebral ischaemia (Astrup etal., 1977; Morawetz etal., 1979) , whereby the ini-tial extinction of spontaneous or evoked electrical activity has to be sustained by continuous or increasing ischaemia for a finite period before irreversible neuronal damage occurs. Thus, the EEG provides a relevant monitor of neuronal function, since a decrease in voltage gives warning of cerebral oligaemia before ischaemic damage would occur. It is not yet known how long it takes to produce cerebral infarction in man when induced hypotension has resulted in a reduction in cerebral blood flow sufficient to produce electrical silence. However, it is likely to take less time than in the young healthy experimental animals studied by Brierley and colleagues (1969) . Indeed, evidence from studies of ischaemic brain damage of a similar arterial boundary zone distribution, following cardiac surgery, suggests that a period of about 7 min major depression of EEG must occur before infarction ensues (Malone, Prior and Scholtz, 1981) .
The MAP threshold at which a pressure-dependent effect begins to occur is of interest. This is at a slightly higher pressure with SNP and probably merely relates to the moment of onset of maximal cerebral arteriolar vasodilatation, which leads to inactivation of the autoregulatory capacity. However, as McDowall (1982) has pointed out, it is incorrect to speak of autoregulation of cerebral blood flow under the particular conditions of hypotension induced by SNP. This cerebral vasodilatation presumably occurs concurrently with dilatation of the systemic vascular bed and the consequent reduction in arterial pressure. Despite this, cerebral perfusion may actually increase as a result of an increased cardiac output with SNP (Wildsmith et al., 1973; Pickard et al., 1981) . This contrasts sharply with the case of TMP where the cardiac output is decreased (Jordan et al., 1971) and, given that autoregulation is in abeyance at these low pressures, this means reduced cerebral blood flow. There is, indeed, evidence from our work in man that there is better maintenance of cerebral electrical activity with SNP than TMP at similar values of hypotension. However, it was possible to detect the onset of an alteration in the relationship between average CFM value and MAP, even though it was rarely as dramatic as in the patient illustrated in figure 2. The evidence arising from the frequent need to use (3-blockade to control tachycardia suggests continuing sympathetic activity in patients receiving both agents. It is surprising that a ganglion blocking drug such as TMP did not obliterate this phenomenon.
Differences in the degree of correlation between MAP and average CFM voltage were apparent when the 10-s measurements during the initial decrease in arterial pressure were compared with the 50-s measurements during the whole period of hypotension in individual patients. In all patients surgical stimulation tended to increase after the initial reduction in arterial pressure had been achieved. This, given the generally light level of anaesthesia, tended to lead to more variable traces and obscure the simple relationship between arterial pressure and EEG. Furthermore, in patients receiving sodium nitroprusside the initial decrease was achieved over a relatively short period, limiting the number of measurements obtainable and, thus, the possibility of achieving significant correlation; these patients also tended to have longer periods of hypotension (90 min on average, compared with 70 min for patients receiving trimetaphan) with a greater possibility of other factors affecting the EEG as a consequence. This may explain our inability to show a significant difference between the two drugs when measurements during the whole period of hypotension were included.
The automatic frequency analysis supported the evidence from the CFM traces. There was a consistent decrease in the summed amplitudes from each of the traditional EEG frequency bands and most significantly in the delta, upper alpha and lower beta ranges as MAP decreased towards target values. This contrasted with the infrequent and inconsistent alterations in the percentage of total activity falling in each frequency band which rendered indices such as slow:fast frequency ratios and mean frequency ineffective. The relatively light level of anaesthesia in our patients contrasts with that in many of the earlier experimental studies where decreases in faster and increases in slower EEG frequencies were reported as evidence of impending cerebral ischaemia (Sugar and Gerard, 1938; Gibbs, Williams and Gibbs, 1940) . Thus, frequency analysis of the EEG provided inconsistent changes during hypotension and offered no advantage over the CFM recording.
Patients are monitored during induced hypotension to reduce unnecessary risks. Clearly, guarding against unexpected or exceptional decreases in MAP by intra-arterial pressure monitoring has proved of major importance in this respect. However, it is quite unpredictable in which patients the cerebral circulation is unable to tolerate reductions in MAP to less than about 60 mm Hg. This implies that direct cerebral monitoring is mandatory, should it become necessary to decrease arterial pressure below this value. The methods need to be simple but effective. This study has demonstrated that a suitable measure is total EEG power or the amplitude envelope of filtered EEG as provided by the CFM.
The evidence from the present study also raises the question as to whether decreases in arterial pressure to less than a mean of 60 mm Hg are ever justified during routine surgery. The question is reinforced by reports that a decrease in blood loss is achieved mainly by quite modest decrease of arterial pressure and that greater hypotension does not produce greater benefit (Donald, 1982) . Our evidence also supports that of Stoyka and Schutz (1975) , Michenfelder and Theye (1977) , Maekawa, McDowall and Okuda (1979) and Ishikawa and McDowall (1981) that, if even greater hypotension is required, sodium nitroprusside is the agent of choice to ensure the safety of the brain.
